FDA Granted Fast Track Designation for Genervona s Breakthrough...

In a huge victory for ALS sufferers, FDA granted Genervon Biopharmaceuticals a fast track designation for its first in class highly effective multi-target master regulator biotechnology drug GM604 for ALS.

http://www.businesswire.com/news/topix/20130626006583/en